Bank Julius Baer & Co. Ltd, Zurich
BankPosition in LITS — Lite Strategy, Inc.
CIK 1544599
ZURICH, V8
Position in LITS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,523
New position
Shares Held
2,175
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank Julius Baer & Co. Ltd, Zurich holds $177,704,514 across 10 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
319,371 | $158,641,156 | |
| 2 | MRNA |
Moderna, Inc.
|
93,920 | $6,577,217 | |
| 3 | BNTX |
BioNTech SE
|
61,701 | $5,741,278 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
16,575 | $4,989,572 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
13,178 | $718,728 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
12,000 | $468,120 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
718 | $447,701 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
1,710 | $58,687 |
All Filings in LITS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,523 | 2,175 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||